Category Archives: Kyle Dennis Biotech Nucleus

Right now stocks are moving on fear and uncertainty. And of course, that sends volatility through the roof. It also means that most stocks will be correlated. For example, it’s not uncommon to see every sector trade lower when we … Continue reading →

I call my edge trades profit buckets.  They are highly profitable setups or pattern that have proven to be consistent winners. Now, when it comes to my number one profit bucket– it’s trading biotech catalyst events. You see, while everyone is talking … Continue reading →

With stocks brushing up against all-time highs… it’s become harder and harder to find value in the market. However, that is where turning to options can become advantageous. You see, with options trading the possibilities are endless. For example, if … Continue reading →

With names like McDonald’s, Amazon, and Starbucks, all releasing quarterly reports this week, it’s natural to see earnings stocks take the spotlight. However, they aren’t the only stocks moving. In fact, biotech stocks remain among the top gainers on Wall … Continue reading →

While earnings season just began, we’ve already seen a fair share of volatility from stock reporting. For example, the other day, Netflix disappointed on its Q2 subscriber growth numbers, which crushed the stock price by nearly 11% overnight. On the … Continue reading →

Over the last year: Amarin Corp jumped from $2.35 to $21.07 PaySign, Inc. spiked from a low of $2.41 to $16.77 Axsome Therapeutics has catapulted from $1.94 to as high as $28.00 Imagine getting in at the lows and riding … Continue reading →

If you don’t know, I didn’t start to make real, life-changing money until I starting scaling up on my biotech trades. Over the years, I’ve been able to understand what moves biotech stocks… and a lot of the times it’s due … Continue reading →

I trade one of the fastest and most lucrative sectors on the planet– biotech. Source: Bloomberg The type of moves that biotech stocks have is unprecedented. And I’m sure that I wouldn’t be approaching nearly $7M in career trading profits … Continue reading →